Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

18,214 total articles

Global Ship Lease Reports Results for the Second Quarter of 2026

Global Ship Lease Reports Results for the Second Quarter of 2026

Global Ship Lease reported solid operating results for Q2 2026, including $198.7 million in operating revenue and $89.3 million in net income available to common shareholders. The company announced an order for 15 modern mid-size containerships valued at $1.33 billion, with multi-year charters secured, enhancing future earnings visibility. Contract…

Jupiter Neurosciences, Inc. Announces Reverse Stock Split

Jupiter Neurosciences, Inc. Announces Reverse Stock Split

Jupiter Neurosciences, Inc., a clinical-stage biopharmaceutical company, announced a 1-for-75 reverse stock split effective August 6, 2026, aimed at increasing the share price to regain compliance with Nasdaq's minimum bid price requirements. The stock will trade on a post-split basis from August 7, 2026, under the ticker JUNS. The reverse split wi…

Safe Harbor Financial Series B Preferred Conversion Price and Warrant Exercise Price Reset to $1.5528 Following Conclusion of Temporary Reduction Period

Safe Harbor Financial Series B Preferred Conversion Price and Warrant Exercise Price Reset to $1.5528 Following Conclusion of Temporary Reduction Period

Safe Harbor Financial announced the end of the temporary reduction period for its Series B Convertible Preferred Stock conversion price and associated warrant exercise price, both reverting to $1.5528. During the reduction period, significant conversions of preferred stock into common stock occurred, simplifying the company's capital structure and …

YETI Holdings, Inc. Announces Investor Day on September 17, 2026

YETI Holdings, Inc. Announces Investor Day on September 17, 2026

YETI Holdings, Inc. announced it will hold an Investor Day on September 17, 2026, in Austin, Texas. The event will feature presentations from the leadership team discussing the company's long-term strategy. It will be accessible both in-person and via a live webcast through the company's investor relations website. The company is known for its inno…

CoreCivic Sells Two Additional Detention Facilities

CoreCivic Sells Two Additional Detention Facilities

CoreCivic has sold its Prairie Correctional Facility and Midwest Regional Reception Center to the U.S. Department of Homeland Security for a combined gross price of $734 million. After taxes and transaction costs, net proceeds are expected to be approximately $522.5 million, which the company plans to use for general corporate purposes such as debt…

Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton

Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton

Lifeward Ltd. has launched a six-month pilot program with Ottobock Care to increase patient access to the ReWalk® 7 Personal Exoskeleton across the U.S. The partnership leverages Ottobock Care's clinical expertise and nationwide clinic network to enhance patient evaluation, training, and follow-up, aiming to scale ReWalk's commercial reach and acce…

ImageneBio Reports Second Quarter 2026 Financial Results

ImageneBio Reports Second Quarter 2026 Financial Results

ImageneBio announced its financial results for Q2 2026 alongside clinical progress for its lead candidate, olevaprubart, a differentiated anti-OX40 monoclonal antibody targeting immunological diseases such as atopic dermatitis and alopecia areata. The Phase 2b trial in moderate-to-severe atopic dermatitis is advancing as planned with an amended pro…

High Roller Technologies Schedules Conference Call to Provide a Business Update and Discuss Second Quarter 2026 Financial Results

High Roller Technologies Schedules Conference Call to Provide a Business Update and Discuss Second Quarter 2026 Financial Results

High Roller Technologies, a publicly traded company on NYSE (ticker: ROLR) specializing in online gaming and prediction markets, announced a conference call on August 11, 2026, to discuss its Q2 financial results and provide a business update. Management will also highlight strategic initiatives, including a planned launch of prediction markets. Th…

Damora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis

Damora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis

Damora Therapeutics announced the initiation of the global Phase 1/1b CLARITY-101 clinical trial to evaluate DMR-001, a novel monoclonal antibody designed to target mutant calreticulin (mutCALR) in patients with essential thrombocythemia and myelofibrosis. Preclinical data showed DMR-001 has significantly higher binding potency and longer half-life…

Global Indemnity Group, LLC Reports Financial Results for the three and six months ended June 30, 2026

Global Indemnity Group, LLC Reports Financial Results for the three and six months ended June 30, 2026

Global Indemnity Group, LLC reported strong financial results for the three and six months ended June 30, 2026. The company posted an 8% increase in quarterly net income to $11.1 million, driven by a favorable loss ratio of 53.8%. Belmont Core segment gross written premiums grew by 7% in Q2. For the six months, net income surged to $15.3 million fr…

Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026

Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026

Ascentage Pharma, a global biopharmaceutical company focused on cancer therapies, will release its unaudited six-month interim results for 2026 on August 19, 2026. The company will host investor webcasts in English and Mandarin, providing updates on its drug pipeline, ongoing Phase III clinical trials, and partnerships with key industry players. Th…

Kura Oncology to Report Second Quarter Financial Results

Kura Oncology to Report Second Quarter Financial Results

Kura Oncology, a biopharmaceutical company specializing in precision cancer medicines, announced it will release its second quarter 2026 financial results after market close on August 12, 2026, followed by a webcast and conference call. The company is focused on developing small molecule drug candidates targeting cancer signaling pathways and is cu…

CervoMed to Participate in Fireside Chat to Highlight Recent Progress in the Neflamapimod Clinical Development Program at the Canaccord Genuity 46th Annual Growth Conference

CervoMed to Participate in Fireside Chat to Highlight Recent Progress in the Neflamapimod Clinical Development Program at the Canaccord Genuity 46th Annual Growth Conference

CervoMed Inc., a clinical-stage biotech company focused on treatments for age-related brain disorders, announced management's participation in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference. They will discuss recent advancements in the clinical development of neflamapimod, their lead drug targeting neuroinflammation and neur…

Medline Reports Second Quarter and First Six Months 2026 Results

Medline Reports Second Quarter and First Six Months 2026 Results

Medline Inc. reported an 11.6% increase in second-quarter net sales to $7.7 billion and a 13.4% increase in Adjusted EBITDA to $1.1 billion for Q2 2026, driven by strong organic sales growth and new customer signings. However, net income decreased by 58.3% to $139 million due to a $336 million loss from a fire at the Tracy, California distribution …

Bioventus Reports Second Quarter Financial Results

Bioventus Reports Second Quarter Financial Results

Bioventus Inc. announced its second quarter 2026 financial results, reporting a 4% increase in revenue to $153.2 million, driven largely by double-digit growth in Pain Treatments. GAAP earnings improved markedly to $0.47 per diluted share from $0.11 in the prior year, supported by the removal of a $24.6 million valuation allowance on deferred tax a…

Stardust Power Announces Offtake Agreement

Stardust Power Announces Offtake Agreement

Stardust Power Inc. announced a non-binding Letter of Intent with Charge CCCV LLC (C4V) to supply battery-grade lithium carbonate from its Muskogee, Oklahoma refinery. The agreement outlines phased demand projections through 2030, reinforcing Stardust's role in the growing U.S. domestic battery supply chain and supporting C4V's expanding battery ma…

EVgo Inc. Reports Second Quarter 2026 Results

EVgo Inc. Reports Second Quarter 2026 Results

EVgo Inc. announced its second quarter 2026 financial results, highlighting a 19% year-over-year increase in charging network revenue to $61 million and a 24% increase in operational charging stalls. The company signed a significant agreement with Tesla to deploy EVgo Superchargers, enhancing its fast-charging infrastructure across the U.S. Despite…

Holley Reports Second Quarter 2026 Results

Holley Reports Second Quarter 2026 Results

Holley Performance Brands announced a 3.2% increase in net sales to $172 million for Q2 2026, driven by growth in three of its four business segments. Despite reporting a net loss of $2.4 million due to a $28.3 million loss on sale of non-core assets, adjusted net income and free cash flow increased significantly. The company continued reducing deb…